 Dronabinol
"Dronabinol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A psychoactive compound extracted from the resin of Cannabis sativa (marihuana, hashish). The isomer delta-9-tetrahydrocannabinol (THC) is considered the most active form, producing characteristic mood and perceptual changes associated with this compound.
| Descriptor ID |
D013759
|
| MeSH Number(s) |
D02.455.849.090.810
|
| Concept/Terms |
Dronabinol- Dronabinol
- delta(9)-THC
- 9-ene-Tetrahydrocannabinol
- 9 ene Tetrahydrocannabinol
- THC
- delta(1)-Tetrahydrocannabinol
- delta(1)-THC
- delta(9)-Tetrahydrocannabinol
- Tetrahydrocannabinol
|
Below are MeSH descriptors whose meaning is more general than "Dronabinol".
Below are MeSH descriptors whose meaning is more specific than "Dronabinol".
This graph shows the total number of publications written about "Dronabinol" by people in this website by year, and whether "Dronabinol" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 0 | 2 | 2 | | 2011 | 1 | 1 | 2 | | 2012 | 2 | 3 | 5 | | 2013 | 1 | 1 | 2 | | 2014 | 2 | 0 | 2 | | 2015 | 2 | 1 | 3 | | 2016 | 1 | 0 | 1 | | 2017 | 1 | 1 | 2 | | 2018 | 1 | 0 | 1 | | 2019 | 4 | 2 | 6 | | 2020 | 2 | 4 | 6 | | 2021 | 6 | 8 | 14 | | 2022 | 2 | 8 | 10 | | 2023 | 1 | 7 | 8 | | 2024 | 7 | 5 | 12 | | 2025 | 14 | 4 | 18 |
To return to the timeline, click here.
Below are the most recent publications written about "Dronabinol" by people in Profiles.
-
ElHassan NO, Farnam C, Thompson JW, Stanley N, Hayes CJ, Li C, Mourani PM, Hudson TJ, Mcgehee R, Martin BC. From card to cradle: examining medical cannabis purchasing among pregnant women in Arkansas. Am J Obstet Gynecol MFM. 2026 Feb; 8(2):101857.
-
Swatek J, Wang GS, Labay L. Delta-9 THC detection in the young pediatric postmortem population: 2018-2024. Child Abuse Negl. 2025 Dec; 170:107763.
-
Skrzynski CJ, Mueller RL, Bidwell LC, Bryan AD, Hutchison KE. Cannabis use measurement: Identifying the optimal metric for broad research applications. Addiction. 2026 Feb; 121(2):331-339.
-
Li T, Wang GS, Brooks-Russell A, Tung G, Leslie L, Rittiphairoj T, Oberste JP, Yim TW, Bero L, Samet JM. Methodological challenges and actionable recommendations in studying the health effects of high-concentration THC products. Am J Epidemiol. 2025 Oct 07; 194(10):3050-3061.
-
Wade NE, Wallace AL, Baca R, Andrade G, Happer JP, Courtney KE, Christians U, Sempio C, Klawitter J, Huestis MA, Jacobus J. Cannabinoid profiling across toxicology samples in adolescents and young adults by route of administration and in relation to depression symptoms. J Anal Toxicol. 2025 Oct 01; 49(8):567-575.
-
VanderVeen BN, Cardaci TD, Unger CA, NeSmith MM, Freeman JC, Bastian AV, Roark K, Upadhyay M, Levy AG, Bullard BM, McDonald SJ, Velázquez KT, Enos RT, Kubinak JL, Hofseth LJ, Hebert JR, Fan D, Murphy EA. Cannabis improves metabolic dysfunction and macrophage signatures in obese mice. Am J Physiol Cell Physiol. 2025 Oct 01; 329(4):C1316-C1331.
-
Strickland JC, Tilton HE, Patton NM, Vandrey R, Austin Zamarripa C, Spindle TR, Lee DC, Bergeria CL, Wolinsky D, Klawitter J, Sempio C, Campos-Palomino J, Christians U, Feldner MT, Irons JG, Bonn-Miller MO. Effect of caffeine and cannabidiol (CBD) co-administration on ?9-tetrahydrocannabinol (?9-THC) subjective effects, performance impairment, and pharmacokinetics. Neuropsychopharmacology. 2025 Nov; 50(12):1827-1835.
-
Dooley G, Godbole S, Wrobel J, Henthorn T, Brooks-Russell A, Limbacher S, Kosnett M. Comparison of ?9-tetrahydrocannabinol in venous and capillary blood following ad libitum cannabis smoking by occasional and daily users. J Anal Toxicol. 2025 Sep 01; 49(7):476-484.
-
Martin-Willett R, Skrzynski CJ, Bryan AD, Bidwell LC. Effects of Cannabinoids on Emotional States and Alcohol Use Among Underrepresented Groups: Moderation by Perceived Discrimination. Hum Psychopharmacol. 2025 Sep; 40(5):e70016.
-
Rittiphairoj T, Leslie L, Oberste JP, Yim TW, Tung G, Bero L, Riggs P, Hutchison K, Samet J, Li T. High-Concentration Delta-9-Tetrahydrocannabinol Cannabis Products and Mental Health Outcomes : A Systematic Review. Ann Intern Med. 2025 Oct; 178(10):1429-1440.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|